{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T17:58:42Z","timestamp":1708019922939},"reference-count":67,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"unspecified","delay-in-days":4749,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Law. Med. Ethics"],"published-print":{"date-parts":[[2008]]},"abstract":"<jats:p>Molecular genetic testing has increasingly been incorporated into clinical medicine, and this trend is likely to accelerate in the future. The introduction of genetic testing into medical practice is beginning to collide head on with patents that claim ownership of correlations between human genetic variants and predisposition to disease, response to therapeutic drugs, and susceptibility to pharmacologic side effects. Patent holders or licensees of genes, genetic variants, and their genotype-phenotype correlations are already using the threat of litigation to monopolize genetic tests for important well-known syndromes like Duchenne Muscular Dystrophy and inherited breast and ovarian cancer, in addition to a host of less commonly discussed conditions.<\/jats:p>","DOI":"10.1111\/j.1748-720x.2008.00243.x","type":"journal-article","created":{"date-parts":[[2008,3,4]],"date-time":"2008-03-04T00:16:39Z","timestamp":1204589799000},"page":"141-149","source":"Crossref","is-referenced-by-count":5,"title":["<i>LabCorp v. Metabolite Laboratories:<\/i>The Supreme Court Listens, but Declines to Speak"],"prefix":"10.1017","volume":"36","author":[{"given":"Roger D.","family":"Klein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurice J.","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2021,1,1]]},"reference":[{"key":"S1073110500010366_bib27","unstructured":"27 See Chakrabarty, supra note 25, at 309."},{"key":"S1073110500010366_bib8","unstructured":"8 Diamond v. Diehr, 450 U.S. 175, 185 (1981)."},{"key":"S1073110500010366_bib20","unstructured":"20 See LabCorp, supra note 16."},{"key":"S1073110500010366_bib64","unstructured":"65 Pollack, A. , \u201cRivals Laying Siege to Amgen's Near Monopoly in Anemia Drugs,\u201d New York Times, December 23, 2005, at C1, Late Edition."},{"key":"S1073110500010366_bib55","unstructured":"56 See Leonard, , supra note 2."},{"key":"S1073110500010366_bib7","unstructured":"7 35 U.S.C. \u00a7 101 (2004)."},{"key":"S1073110500010366_bib35","unstructured":"35 Parker v. Flook, 437 U.S. 584 (1978)."},{"key":"S1073110500010366_bib14","unstructured":"14 Id., at 7\u20139."},{"key":"S1073110500010366_bib6","doi-asserted-by":"crossref","unstructured":"6 35 U.S.C. \u00a7\u00a7 101\u2013103 (2004).","DOI":"10.1215\/00382876-103-1-101"},{"key":"S1073110500010366_bib15","unstructured":"15 Id., at 10."},{"key":"S1073110500010366_bib24","first-page":"301","article-title":"\u201cBack to the Future: Rethinking the Product of Nature Doctrine as a Barrier to Biotechology Patents,\u201d","volume":"85","author":"Conley","year":"2003","journal-title":"Journal of the Patent and Trademark Office Society"},{"key":"S1073110500010366_bib4","unstructured":"4 See, e.g., Rice v. Sioux City Memorial Park Cemetary, Inc., 349 U.S. 70, 70\u201381 (1955)."},{"key":"S1073110500010366_bib48","unstructured":"49 Barzo, G. , \u201cLawsuit Heats Up over Patent on Common Prenatal Test,\u201d American Medical News, January 12, 1998, at 1."},{"key":"S1073110500010366_bib58","unstructured":"59 Athena Diagnostics Web site, available at <http:\/\/www.athenadiagnostics.com\/content\/about\/> (last visited September 21, 2007)."},{"key":"S1073110500010366_bib36","unstructured":"36 Arrhythmia Research Tech. v. Corazonix Corp., 958 F.2d 1053 (Fed. Cir. 1992) (EKG system that utilizes programmed computer to analyze electrocardiographic signals is statutory subject matter); In re Alappat, 33 F.3d 1526 (Fed. Cir. 1994) (en banc) (digital processing circuitry programmed to generate antialiased oscilloscope tracing is statutory subject matter); State St. Bank & Trust v. Signature Fin. Group, 149 F.3d 1368 (Fed. Cir. 1998) (data processing system used to administer investment fund is statutory subject matter); ATT Corp. v Excel Commc\u2019ns Inc., 172 F.3d 1352 (Fed. Cir. 1999) (computerized system for recording and billing long distance telephone calls that has ability to recognize called party's long distance carrier is statutory subject matter)."},{"key":"S1073110500010366_bib63","unstructured":"64 Myriad Genetics, Myriad Genetics Reports Financial Results for Fiscal 2006, News Release, August 22, 2006, available at <http:\/\/www.myriad.com\/news\/release\/898035> (last visited September 21, 2007)."},{"key":"S1073110500010366_bib34","unstructured":"34 Gottschalk v. Benson, 409 U.S. 63 (1972)."},{"key":"S1073110500010366_bib29","unstructured":"29 Parke-Davis & Co. v. H. K. Mulford & Co., 189 F. 95 (S.D.N.Y. 1911), aff\u2019d, 196 F. 496 (2d Cir. 1912)."},{"key":"S1073110500010366_bib18","unstructured":"18 Id., at 1364."},{"key":"S1073110500010366_bib32","unstructured":"32 See e.g., Amgen v. Chugai Pharmaceutical Co., 927 F.2d 1200, 1206 (Fed Cir 1991) (\u201cA gene is a chemical compound, albeit a complex one\u2026\u201d)."},{"key":"S1073110500010366_bib44","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(87)90026-1"},{"key":"S1073110500010366_bib65","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2007.087056"},{"key":"S1073110500010366_bib26","unstructured":"26 Diamond v. Diehr, 450 U.S. 175 (1980)."},{"key":"S1073110500010366_bib10","unstructured":"10 Brief for Petitioner on Writ of Certiorari at 5, Laboratory Corp. of America v. Metabolite Labs., Inc., 126 S.Ct. 2921 (2006), dismissed as improvidently granted."},{"key":"#cr-split#-S1073110500010366_bib49.1","unstructured":"50 Brief for Respondents on Writ of Certiorari at 43-46, Laboratory Corp. of America v. Metabolite Labs., Inc., 126 S.Ct. 2921 (2006), dismissed as improvidently granted"},{"key":"#cr-split#-S1073110500010366_bib49.2","unstructured":"Brief for the United States as Amicus Curiae on Petition for a Writ of Certiorari at 14, Laboratory Corp. of America v. Metabolite Labs., Inc., 126 S.Ct. 2921 (2006), dismissed as improvidently granted."},{"key":"S1073110500010366_bib5","unstructured":"5 Laboratory Corp. of America v. Metabolite Labs., Inc., 126 S.Ct. 2921 (2006), dismissed as improvidently granted."},{"key":"S1073110500010366_bib38","unstructured":"38 State Street Bank & Trust Co. v. Signature Financial Group, 149 F.3d 1368."},{"key":"S1073110500010366_bib51","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nbt0907-989","article-title":"\u201cGene Patents and Genetic Testing in the United States,\u201d","volume":"25","author":"Klein","year":"2007","journal-title":"Nature Biotechnology"},{"key":"S1073110500010366_bib46","unstructured":"47 Id., at 2928."},{"key":"S1073110500010366_bib56","unstructured":"57 Murphy, G. M. Schatzberg, A. F. , \u201cMethod to determine the risk for side effects of an SSRI treatment in a person,\u201d U.S. Patent No. 7,083,921, filed August 29, 2002, and issued August 1, 2006."},{"key":"S1073110500010366_bib37","unstructured":"37 See Diehr, , supra note 8, at 187."},{"key":"S1073110500010366_bib60","volume-title":"Breakthrough: The Race to Find the Breast Cancer Gene","author":"Davies","year":"1996"},{"key":"S1073110500010366_bib45","unstructured":"46 See LabCorp, , supra note 44, at 2927 (Justice Breyer dissenting)."},{"key":"S1073110500010366_bib33","unstructured":"33 See Diehr, , supra note 26."},{"key":"S1073110500010366_bib2","doi-asserted-by":"publisher","DOI":"10.1097\/00001888-200212001-00010"},{"key":"S1073110500010366_bib62","unstructured":"63 Myriad Genetics, \u201cGenetic Testing for Hereditary Cancer,\u201d available at <http:\/www.myriad.com\/products\/cancerrisk.php> (last visited September 21, 2007)."},{"key":"S1073110500010366_bib39","unstructured":"39 See Diehr, , supra note 8, at 189\u2013191."},{"key":"S1073110500010366_bib41","unstructured":"41 See State Street, supra note 38, at 1375. The omitted footnote reads, \u201cOf course, the subject matter must fall into at least one category of statutory subject matter.\u201d42. See Diehr, , supra note 8, at 184."},{"key":"S1073110500010366_bib53","unstructured":"54 Shattuck-Eidens, D. M. Simard, J. Durocher, F. Mitsuuru, E. Nakamura, Y. , \u201cLinked breast and ovarian cancer susceptibility gene,\u201d U.S. Patent No. 5,709,999, filed June 7, 1995, and issued January 20, 1998."},{"key":"S1073110500010366_bib57","unstructured":"58 Kary B. Mullis won the 1993 Nobel Prize in Chemistry for his invention of the polymerase chain reaction (PCR)."},{"key":"S1073110500010366_bib47","unstructured":"48 Bogart, M. , \u201cMethod for assessing placental dysfunction,\u201d U.S. Patent No. 4,874,693, filed October 10, 1986, and issued October 17, 1989."},{"key":"S1073110500010366_bib54","unstructured":"55 See Klein, , supra note 52."},{"key":"S1073110500010366_bib12","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2003.1.62"},{"key":"S1073110500010366_bib59","unstructured":"60 Athena Diagnostics, \u201cList of Patents,\u201d available at <http:\/\/www.athenadiagnostics.com\/content\/about\/patents> (last visited September 21, 2007); the company also has patent rights to a number of immunologically related gene patents having less direct relationships with diseases."},{"key":"S1073110500010366_bib13","unstructured":"13 See supra note 10, at 7."},{"key":"S1073110500010366_bib11","first-page":"1649","article-title":"\u201cRole of vitamin B12 in Methionine Synthesis,\u201d","volume":"25","author":"Weissbach","year":"1966","journal-title":"Federation Proceedings"},{"key":"S1073110500010366_bib9","unstructured":"9 Allen, R. H. Stabler, S. P. Lindenbaum, J. , \u201cAssay for sulfhydryl amino acids and methods for detecting and distinguishing cobalamin and folic acid deficiency,\u201d U.S. Patent 4,940,658, filed November 20, 1986, and issued July 10, 1990."},{"key":"S1073110500010366_bib1","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.5858\/2006-130-1603-OKTPAL","article-title":"\u201cOpportunity Knocks: The Pathologist as Laboratory Genetics Consultant,\u201d","volume":"130","author":"Klein","year":"2006","journal-title":"Archives of Pathology and Laboratory Medicine"},{"key":"S1073110500010366_bib42","unstructured":"43 Id."},{"key":"S1073110500010366_bib28","unstructured":"28 Kuehmsted v. Farbenfabriken, 179 F. 701 (7th Cir. 1910), cert. denied, 220 U.S. 622 (1911)."},{"key":"S1073110500010366_bib66","unstructured":"67 Transcript of Oral Argument at 40, Laboratory Corp. of America v. Metabolite Labs., Inc., 126 S.Ct. 2921 (2006), dismissed as improvidently granted."},{"key":"S1073110500010366_bib52","unstructured":"53 See Leonard, , supra, note 2; Cho, et al., supra, note 2."},{"key":"S1073110500010366_bib40","unstructured":"40 Id."},{"key":"S1073110500010366_bib21","unstructured":"21 See LabCorp, supra note 17, at 1372."},{"key":"S1073110500010366_bib17","unstructured":"17 Metabolite Labs. v. Laboratory Corp. of America, 370 F. 3d 1354, 1365 (2004)."},{"key":"S1073110500010366_bib22","unstructured":"22 Order, February 28, 2005, Laboratory Corp. of America v. Metabolite Labs., Inc., 125 S.Ct. 1413 (2005) (citing Diamond v. Diehr, 450 U.S. 175 [1981])."},{"key":"S1073110500010366_bib3","unstructured":"3 Laboratory Corp. of America v. Metabolite Labs., Inc., Order Granting Certiorari, 126 S.Ct. 543 (2005)."},{"key":"S1073110500010366_bib61","unstructured":"62 ThermoFisher Scientific, Fisher Scientific Expands Presence in Molecular Diagnostics; Company to Acquire Athena Diagnostics from Behrman Capital and Purchase 9 Percent of Nanogen, News Release, March 16, 2006, available at <http:\/\/ir.thermofisher.com\/phoenix.zhtml?c=89145&p=irol-newsArticle&ID=914979> (last visited September 21, 2007)."},{"key":"S1073110500010366_bib50","doi-asserted-by":"publisher","DOI":"10.1086\/scr.2002.3109720"},{"key":"S1073110500010366_bib16","unstructured":"16 Metabolite Labs. v. Laboratory Corp. of America, No. 99-Z-870 (D. Colo. November 21, 2001)."},{"key":"S1073110500010366_bib31","unstructured":"31 In re Bergstrom, 427 F.2d 1394 (C.C.P.A. 1970) (PGE, PGF)."},{"key":"S1073110500010366_bib30","unstructured":"30 Merck & Co. v. Olin Mathieson Chemical Corp., 253 F.2d 156 (4th Cir. 1958)."},{"key":"S1073110500010366_bib43","unstructured":"44 Laboratory Corp. of Am. v. Metabolite Labs., Inc., 126 S.Ct. 2921, 2927 (2006), dismissed as improvidently granted (Justice Breyer dissenting) (\u201cBut this case is not at the boundary. It does not require us to consider the precise scope of the \u2018natural phenomenon\u2019 doctrine or any other difficult issue. In my view claim 13 is invalid no matter how narrowly one reasonably interprets that doctrine.\u201d)"},{"key":"S1073110500010366_bib19","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMhpr063626","article-title":"\u201cMedical-Process Patents \u2013 Monopolizing the Delivery of Health Care,\u201d","volume":"355","author":"Kesselheim","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"S1073110500010366_bib25","unstructured":"25 Diamond v. Chakrabarty, 447 U.S. 303 (1980)."},{"key":"S1073110500010366_bib23","unstructured":"23 Brief for the United States as Amicus Curiae on Petition for a Writ of Certiorari at 5\u20137, 15\u201319, supra note 5."}],"container-title":["Journal of Law, Medicine &amp; Ethics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1748-720X.2008.00243.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1111\/j.1748-720X.2008.00243.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1073110500010366","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T20:27:31Z","timestamp":1684268851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1073110500010366\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"alternative-id":["S1073110500010366"],"URL":"https:\/\/doi.org\/10.1111\/j.1748-720x.2008.00243.x","relation":{},"ISSN":["1073-1105","1748-720X"],"issn-type":[{"value":"1073-1105","type":"print"},{"value":"1748-720X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008]]}}}